Trulieve Cannabis Corp.
TRLVHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Oct 26, 2026
Scan Results
Daily timeframeTrulieve Cannabis Corp. operates as a cannabis retailer in the United States. Valued at $2.01B, TRLV is a mid-cap name in its sector. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.
Market Cap
$2.01B
Beta
1.80
P/E (TTM)
—
P/E (Fwd)
18.72
EPS (TTM)
$-2.43
EPS (Fwd)
$0.56
ROE
-47.6%
ROA
3.3%
Cash
$325.4M
Total Debt
$577.9M
Free CF
$232.0M
52W Change
42.2%
Annual Financials
Cash vs Debt
Where TRLV stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, TRLV finished 11.38% above its 150-day moving average ($9.23) and 17.89% above its 200-day moving average ($8.72). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TRLV overbought or oversold?
At the October 20, 2026 close, TRLV's RSI(14) was 24.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, TRLV has $325.4M in cash with $577.9M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $232.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -47.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $1.22B (2022) to $1.18B (2025).
Trulieve Cannabis Corp.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Trulieve Cannabis Corp. and its sector.